Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue July 2015
 •  The Latest Cosmetic Import Refusals  •  Croda Offers Color Cosmetic Innovations  •  Burt Shavitz Passes at 80  •  Redken Names Latest Brand Muse  •  Unit Pack Adds 3D Printing
Print

Galderma S.A. has gained full rights to distribute



Published August 1, 2014
Related Searches: president global products health
Post a comment
Galderma S.A. has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International, Inc. The expansion into aesthetic and corrective dermatology in the US and Canada completes Galderma’s global skin health footprint and extends its leadership in aesthetic medicine worldwide, the company said.

“We at Galderma are delighted to bring Restylane, Perlane, Emervel, and Dysport home in the US and Canada as is the case in dozens of countries around the world. Adding Sculptra to our global portfolio allows us to bring additional indications to our broad range of medical solutions for people with skin needs,” said Humberto C. Antunes, CEO and president of Galderma worldwide.

“Our science-based approach to fillers and muscle relaxants takes our solutions beyond the aesthetic level to an integral part of holistic medicine, where maintaining, preserving and restoring the health of the skin is as important and as relevant as treating or correcting conditions. With Restylane, Perlane, and Dysport, as well as the innovations to come, we complement our line of prescription and self-medication products to give physicians an arsenal of effective solutions,” added Antunes.  


blog comments powered by Disqus